Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)
China flag China · Delayed Price · Currency is CNY
39.66
-3.88 (-8.91%)
May 20, 2026, 12:34 PM CST

SHE:002940 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
607.14687.41697.38859.75735.47688.91
Trading Asset Securities
283.96102.2636.041069.359.6
Cash & Short-Term Investments
891.09789.67733.42869.75804.76748.51
Cash Growth
15.17%7.67%-15.68%8.08%7.52%-12.36%
Accounts Receivable
228.63218.89234.32244.86295.51301.32
Other Receivables
3.462.719.8521.456.7717.27
Receivables
232.09221.6244.18266.31302.28318.59
Inventory
512.31447.47503.79393.44293.23299.6
Other Current Assets
30.8527.1117.4832.4351.699.25
Total Current Assets
1,6661,4861,4991,5621,4521,376
Property, Plant & Equipment
616.44617.28603.86615.8445.7474.63
Long-Term Investments
293.08304.84304.7301.41302.15147.34
Goodwill
312.94312.94312.94312.9421.9821.98
Other Intangible Assets
121.16123.57133.55139.1438.7840.05
Long-Term Deferred Tax Assets
39.7239.1250.0632.7722.4420.65
Long-Term Deferred Charges
52.4152.6449.4835.060.981.6
Other Long-Term Assets
13.2914.5721.0720.95312.091.36
Total Assets
3,1152,9512,9753,0202,5962,084
Accounts Payable
458.82434.09485.45402.49320.45335.97
Accrued Expenses
25.0244.77120.24130.41220.56218.67
Short-Term Debt
256.14137.06163.37134.9171.941.76
Current Portion of Long-Term Debt
25.9869.7420.2130.425.02-
Current Portion of Leases
---0.26--
Current Income Taxes Payable
4.2311.75.579.34-2.88
Current Unearned Revenue
22.810.4132.3118.7241.6731.9
Other Current Liabilities
110.95105.2716.395.458.954.1
Total Current Liabilities
903.94813.03843.54731.97788.59595.29
Long-Term Debt
289.5242.26303.5423.95150-
Long-Term Unearned Revenue
19.4417.6416.7817.859.7313.3
Long-Term Deferred Tax Liabilities
10.4610.6712.2913.951.60.06
Total Liabilities
1,2231,0841,1761,188949.93608.64
Common Stock
201.73201.73201.73201.73139.1295.95
Additional Paid-In Capital
708.28708.28684.01723.84782.91824.87
Retained Earnings
811.88794.22712.9674.51577.87478.74
Treasury Stock
-84.1-84.1-74.5-20.12--63.34
Comprehensive Income & Other
8.287.156.46.252.752.64
Total Common Equity
1,6461,6271,5311,5861,5031,339
Minority Interest
245.99239.94267.87246.07143.5136.08
Shareholders' Equity
1,8921,8671,7981,8321,6461,475
Total Liabilities & Equity
3,1152,9512,9753,0202,5962,084
Total Debt
571.62449.05487.08589.52346.961.76
Net Cash (Debt)
319.48340.61246.34280.23457.8746.75
Net Cash Growth
29.90%38.27%-12.10%-38.79%-38.69%-11.34%
Net Cash Per Share
1.581.681.231.402.303.74
Filing Date Shares Outstanding
196.16211.69196.89199.71197.4197.4
Total Common Shares Outstanding
196.16211.69196.89199.71197.4197.4
Working Capital
762.4672.82655.33829.96663.37780.67
Book Value Per Share
8.397.697.777.947.616.78
Tangible Book Value
1,2121,1911,0841,1341,4421,277
Tangible Book Value Per Share
6.185.635.515.687.306.47
Buildings
--447.5435.42314.48319.46
Machinery
--640.01628.95467.67439.73
Construction In Progress
--49.622.5225.3329.94
Source: S&P Global Market Intelligence. Standard template. Financial Sources.